Example, if you want to administer 100mcg of IGF-1 Lr3 into the chest in 2 different areas of the muscle then you would need to divided the dose as follows: 100mcg per administration / 2 chest muscles = 50mcg per muscle 50mcg per muscle / 2 different locations on each muscle = 25mcg per injection Theoretically, the more locations used to administer the IGF-1 Lr3 into the muscle the more places for muscle growth
Is a personal history of pancreatitis a contraindication to Glucagon-like peptide-1 (GLP-1) agonists?
Hazzaa SM, El-Roghy ES, Abd Eldaim MA, Elgarawany GEJES, International PR
But over time, the benefits of improved health, increased mobility, reduced chronic disease burden, and enhanced self-image tend to accumulate
Tirzepatide's mechanism stays within incretin pathways, which is why its weight-loss ceiling sits below retatrutide's in head-to-head modelling